SPX Corp (SPW) 49.44 $SPW SPX Has Returned 41.5% Since

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
SPX Corp (SPW) 49.44 $SPW

SPX Has Returned 41.5% Since SmarTrend Recommendation (SPW)
Comtex SmarTrend(R) - Tue Nov 24, 11:53AM CST
SmarTrend identified a Downtrend for SPX (NYSE:SPW) on March 11th, 2015 at $84.52. In approximately 9 months, SPX has returned 41.50% as of today's recent price of $49.44.
SPW: 49.44 (+1.09)

SPX Down 41.5% Since SmarTrend Downtrend Call (SPW)
Comtex SmarTrend(R) - Tue Nov 17, 10:02AM CST
SmarTrend identified a Downtrend for SPX (NYSE:SPW) on March 11th, 2015 at $84.52. In approximately 8 months, SPX has returned 41.50% as of today's recent price of $49.44.
SPW: 49.44 (+1.09)

Downtrend Call Working As SPX Stock Falls 41.5% (SPW)
Comtex SmarTrend(R) - Tue Nov 10, 9:18AM CST
SmarTrend identified a Downtrend for SPX (NYSE:SPW) on March 11th, 2015 at $84.52. In approximately 8 months, SPX has returned 41.50% as of today's recent price of $49.44.
SPW: 49.44 (+1.09)

SPX Shares Down 41.5% Since SmarTrend's Sell Call (SPW)
Comtex SmarTrend(R) - Mon Nov 02, 4:58PM CST
SmarTrend identified a Downtrend for SPX (NYSE:SPW) on March 11th, 2015 at $84.52. In approximately 8 months, SPX has returned 41.50% as of today's recent price of $49.44.
SPW: 49.44 (+1.09)

41.5% Return Seen to Date on SmarTrend SPX Call (SPW)
Comtex SmarTrend(R) - Mon Oct 12, 9:23AM CDT
SmarTrend identified a Downtrend for SPX (NYSE:SPW) on March 11th, 2015 at $84.52. In approximately 7 months, SPX has returned 41.50% as of today's recent price of $49.44.
SPW: 49.44 (+1.09)

Shares of SPW Down 41.5% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri Oct 02, 4:53PM CDT
SmarTrend identified a Downtrend for SPX (NYSE:SPW) on March 11th, 2015 at $84.52. In approximately 7 months, SPX has returned 41.50% as of today's recent price of $49.44.
SPW: 49.44 (+1.09)

SPX Falls 4.69% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu Sep 24, 4:42PM CDT
SPX (NYSE:SPW) traded in a range yesterday that spanned from a low of $47.89 to a high of $50.70. Yesterday, the shares fell 4.7%, which took the trading range below the 3-day low of $51.23 on volume of 6.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SPW: 49.44 (+1.09)

Look for Shares of SPX to Potentially Rebound after Yesterday's 4.69% Sell Off
Comtex SmarTrend(R) - Thu Sep 24, 4:41PM CDT
SPX (NYSE:SPW) traded in a range yesterday that spanned from a low of $47.89 to a high of $50.70. Yesterday, the shares fell 4.7%, which took the trading range below the 3-day low of $51.23 on volume of 6.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SPW: 49.44 (+1.09)

Toro Set to Join the S&P MidCap 400; SPX, SPX FLOW and Core-Mark to Join the S&P SmallCap 600
PR Newswire - Mon Sep 21, 5:15PM CDT
S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices:
TTC: 86.00 (-0.45), SPW: 49.44 (+1.09), CBK: 2.30 (+0.05), TRAK: 63.16 (+1.05), MHFI: 107.92 (+1.16), CORE: 89.69 (+0.19)

Shares of SPW Down 35.2% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri Sep 18, 10:05AM CDT
SmarTrend identified a Downtrend for SPX (NYSE:SPW) on March 11th, 2015 at $84.52. In approximately 6 months, SPX has returned 35.22% as of today's recent price of $54.75.
SPW: 49.44 (+1.09)

SPX to Present at Morgan Stanley Laguna Conference
PR Newswire - Tue Sep 15, 7:00AM CDT
SPX Corporation (NYSE: SPW) today announced that Chairman, President and Chief Executive Officer Chris Kearney will participate at the Morgan Stanley Laguna Conference in Laguna Beach, California on Friday, September 18, 2015 at 8:00 a.m. Pacific time (11:00 a.m. Eastern time).
FLOW: 28.50 (-1.40), SPW: 49.44 (+1.09), MS: 25.26 (-0.28)

SPX Appoints New Executive Officers Contingent on FLOW Spin-off
PR Newswire - Mon Sep 14, 3:05PM CDT
SPX Corporation (NYSE: SPW) today announced that its Board of Directors appointed the following individuals as executive officers of SPX Corporation to serve contingent on and effective upon completion of the Company's previously announced spin-off of SPX FLOW, Inc.:
SPW: 49.44 (+1.09)

SPX Down 34.9% Since SmarTrend Downtrend Call (SPW)
Comtex SmarTrend(R) - Fri Sep 11, 9:33AM CDT
SmarTrend identified a Downtrend for SPX (NYSE:SPW) on March 11th, 2015 at $84.52. In approximately 6 months, SPX has returned 34.90% as of today's recent price of $55.02.
SPW: 49.44 (+1.09)

SPX announces spin-off of SPX FLOW Inc and pro rata dividend of common stock
M2 - Wed Sep 09, 3:01AM CDT
SPX Corporation (NYSE:SPW) revealed on Tuesday the timing and additional details of the spin-off of SPX FLOW Inc and the board of directors approved the final distribution ratio and a pro rata dividend of the outstanding shares of SPX FLOW common stock, to result in the complete legal and structural separation of the two companies.
SPW: 49.44 (+1.09)

SPX Corporation Declares Spin-Off Dividend of SPX FLOW, Inc. Shares
PR Newswire - Tue Sep 08, 4:30PM CDT
SPX Corporation (NYSE: SPW) today announced the timing and additional details regarding the previously announced spin-off of SPX FLOW, Inc. from SPX Corporation.
FLOW: 28.50 (-1.40), SPW: 49.44 (+1.09)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 30

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 25

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 45

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 59

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 41

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 38

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 34

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Genesys Celebrates Global Recognition as a Top Workplace

Updated Category News Views 50

Genesys Achieves Global Recognition for Workplace Excellence Genesys, a renowned leader in AI-driven experience orchestration, has been proudly certified as a Great Place to Work. This significant accomplishment reflects the overwhelming sentiment from its employees, with a remarkable 90% affirming that Genesys is indeed a fantastic workplace. This statistic represents a...

Continue Reading
Class Action Alert for Twitter Stockholders: Important Updates

Updated Category News Views 198

Understanding the Class Action Lawsuit for Twitter, Inc. Stockholders A significant class action lawsuit has been initiated for individuals and entities who traded Twitter, Inc. stock or options during a specified period. This legal action has garnered substantial attention as it affects numerous investors who believe they suffered losses due to alleged misconduct. Key...

Continue Reading
Rhythm Pharmaceuticals Advances IMCIVREE® for Young Patients

Updated Category News Views 180

Rhythm Pharmaceuticals Receives FDA Acceptance for Priority Review Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company, has announced that the FDA has accepted its supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide). This application has been designated for Priority Review by the FDA, which suggests that patients may gain timely...

Continue Reading
Understanding Market Trends Impacting NCR Atleos Corp's Future

Updated Category News Views 59

Market Sentiment Surrounding NCR Atleos Corp NCR Atleos Corp (NYSE: NATL) has recently caught the attention of investors as its short interest percentage has experienced a notable increase. Currently, approximately 3.76% of the company's shares have been sold short, which translates to about 3.01 million shares. This figure indicates that roughly 6.35% of all regular...

Continue Reading
Leslie’s, Inc. Reports Q2 Fiscal 2025 Earnings and Key Insights

Updated Category News Views 346

Financial Highlights from Leslie’s, Inc. In light of recent developments, Leslie’s, Inc. (NASDAQ: LESL), the premier name in pool and spa care in the U.S., has unveiled its financial results for the second quarter of fiscal year 2025. The company is dedicated to serving both residential and professional customers with quality products and exceptional service. CEO...

Continue Reading